UniFAHS

Livestock farming today still relies heavily on antibiotics to prevent disease and maintain productivity. But growing antimicrobial resistance (AMR), increasing regulation, and pressure from consumers and global buyers are forcing the industry to find safer alternatives without sacrificing efficiency. UniFAHS is building natural, scalable alternatives to antibiotics using bacteriophages — naturally occurring viruses that selectively target harmful bacteria while preserving beneficial ones. Its platform combines a proprietary phage library, patented formulation technology, and tailored farm-level applications to deliver precise, environmentally safe treatments that fit into existing livestock operations. UniFAHS is already working with major agribusiness players including CP Group, Cargill, and JAFPA, and has demonstrated ~230% CAGR alongside attractive unit economics. We see livestock as the starting point. As the industry moves away from routine antibiotic use, UniFAHS has the potential to become a core biological platform for disease prevention, food safety, and more sustainable animal production across Southeast Asia and beyond.